Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AL-TOMICA: Omics Approaches in R/R Acute Leukemias
NCT06626893Recruiting
- Sponsor
- Azienda Ospedaliero-Universitaria di Parma
- Start
- Mar 2022
- Primary completion
- Mar 2025
- Countries
- 1
01
Overview
Open-label, single-arm trial, sponsored by Azienda Ospedaliero-Universitaria di Parma. Primary endpoint: Frequencies of alternative therapies identified for AL patients at 12 months. Started Mar 2022; status: recruiting.
Beyond the preview
Go deeper on NCT06626893.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06626893.